Riverview Trust Company’s West Pharmaceutical WST Stock Holding History

Riverview Trust Company’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-54	Closed	-$17.7K	–	830
2024 Q4	$17.7K	Hold	54	–	–	0.02%	511
2024 Q3	$16.2K	Buy	54 +2	+4%	+$612	0.01%	560
2024 Q2	$17.1K	Hold	52	–	–	0.02%	500
2024 Q1	$20.6K	Buy	+52	New	+$19.2K	0.02%	464
2023 Q4	–	Sell	-52	Closed	-$19.5K	–	643
2023 Q3	$19.5K	Hold	52	–	–	0.02%	392
2023 Q2	$19.9K	Hold	52	–	–	0.02%	367
2023 Q1	$18K	Buy	+52	New	+$15.2K	0.02%	387
2022 Q4	–	Sell	-42	Closed	-$10K	–	876
2022 Q3	$10K	Buy	+42	New	+$12.8K	0.01%	689
2022 Q2	–	Sell	-59	Closed	-$24K	–	877
2022 Q1	$24K	Buy	+59	New	+$23.1K	0.02%	412

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Riverview Trust Company's WST Position: Q1 2025 in Review

Riverview Trust Company sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 54 shares — an estimated $17.7K sold.

Riverview Trust Company first reported a position in WST in Q1 2022 and held it in 9 quarters. The position peaked at $24K in Q1 2022. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

Riverview Trust Company reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Riverview Trust Company sold 54 West Pharmaceutical shares in Q1 2025, an estimated $17.7K.
Riverview Trust Company first reported a position in West Pharmaceutical in Q1 2022 and held it in 9 quarters.
Riverview Trust Company's West Pharmaceutical position peaked at $24K in Q1 2022.
715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.